good manufacturing practice

In a pharmaceutical company called ‘Aministo Pharma,’ the packaging process of Beta-lactam antibiotics was not separated from the main manufacturing area. Also, staffs’ movement between beta-lactam and non-beta-lactam manufacturing areas could be identified. The company’s quality control examinations intended to detect beta-lactam contamination provided limited confidence due to the analytical method limitations. In this situation what measures should be taken by the company according to good manufacturing practice

read schedule M